Profile data is unavailable for this security.
About the company
Cronos Group Inc. is a Canada-based global cannabinoid company engaged in building intellectual property by advancing cannabis research, technology and product development. The Company’s segments include United States and Rest of World. The United States operating segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s international brand portfolio includes Spinach, PEACE NATURALS, and Lord Jones. The Lord Jones are hemp-derived cannabidiol (CBD) brand. Its Lord Jones Hash Fusions is a line-up of premium ice water hash infused pre-rolls. Its PEACE NATURALS offers Peppermint CBD, a blend of CBD extract, quality medium-chain triglycerides (MCT) oil, and a hint of natural peppermint flavor.
- Revenue in CAD (TTM)128.21m
- Net income in CAD-74.61m
- Incorporated2020
- Employees626.00
- LocationCronos Group Inc111 Peter Street, Unit 300TORONTO M5V 2H1CanadaCAN
- Phone+1 (416) 504-0004
- Fax+1 (416) 504-0004
- Websitehttps://thecronosgroup.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beijing Tong Ren Tang Chinese Medicine | 269.14m | 95.37m | 1.26bn | 798.00 | 13.21 | 1.85 | 10.61 | 4.68 | 0.6456 | 0.6456 | 1.82 | 4.62 | 0.3522 | 0.6449 | 2.31 | 1,910,959.00 | 13.64 | 16.71 | 15.50 | 18.75 | 68.67 | 69.88 | 38.73 | 40.72 | 8.59 | -- | 0.0317 | 68.87 | -11.91 | 0.1459 | -16.33 | -1.43 | -16.30 | 7.49 |
| Beijing Foyou Pharma Co Ltd | 629.61m | 96.18m | 1.27bn | 3.44k | 13.14 | 1.90 | -- | 2.01 | 1.06 | 1.06 | 6.95 | 7.35 | 0.7482 | 3.46 | 9.58 | 967,165.90 | 11.50 | -- | 14.81 | -- | 65.14 | -- | 15.37 | -- | 2.99 | -- | 0.0316 | -- | 3.07 | -- | 11.36 | -- | -- | -- |
| Pacira Biosciences Inc | 939.66m | 97.13m | 1.28bn | 711.00 | 15.42 | 1.04 | 6.42 | 1.36 | 1.30 | 1.30 | 12.11 | 19.18 | 0.4389 | 1.93 | 7.00 | 958,866.40 | 4.54 | 3.35 | 4.84 | 3.98 | 73.15 | 72.63 | 10.34 | 8.57 | 4.78 | 51.11 | 0.3684 | 0.00 | 1.22 | 14.88 | 163.72 | -- | 0.8761 | -- |
| Shenzhen Chipscreen Biosciences Co Ltd | 103.78m | 19.52m | 1.30bn | 1.06k | 65.25 | 4.06 | -- | 12.52 | 0.2578 | 0.2578 | 1.33 | 4.15 | 0.1761 | 1.66 | 3.97 | 518,248.70 | 2.14 | 1.32 | 2.61 | 1.54 | 86.99 | 93.29 | 12.17 | 6.97 | 2.99 | -- | 0.4037 | 0.00 | -1.18 | 28.81 | 408.09 | 23.31 | 10.23 | -- |
| Cronos Group Inc | 128.21m | -74.61m | 1.31bn | 626.00 | -- | 0.8808 | -- | 10.20 | -0.1958 | -0.2062 | 0.3364 | 3.88 | 0.082 | 2.12 | 5.46 | -- | -4.84 | 6.43 | -4.97 | 7.11 | 14.47 | -10.54 | -59.00 | 147.07 | 27.28 | -- | 0.00 | -- | 0.5672 | 48.40 | 54.99 | -- | -50.99 | -- |
| Nxera Pharma Co Ltd | 145.58m | -80.36m | 1.31bn | 350.00 | -- | 2.23 | -- | 9.00 | -107.30 | -107.30 | 194.96 | 736.60 | 0.1309 | -- | 5.77 | 46,954,280.00 | -7.23 | -0.6588 | -7.78 | -0.7036 | 74.44 | 89.83 | -55.20 | -4.46 | 4.03 | -10.91 | 0.5238 | -- | -18.00 | -- | -1,982.98 | -- | -- | -- |
| Cansino Biologics Inc | 65.39m | -280.88m | 1.31bn | 1.49k | -- | 0.8116 | -- | 20.06 | -6.45 | -6.45 | 1.50 | 22.92 | 0.0332 | 2.37 | 0.4619 | 247,992.10 | -18.93 | -4.27 | -26.69 | -5.60 | -253.78 | -- | -569.97 | -27.72 | 1.86 | -- | 0.3381 | -- | -66.52 | 213.94 | -63.04 | -- | 30.60 | -- |
| F D C Ltd | 320.01m | 50.27m | 1.33bn | 6.37k | 26.75 | 3.86 | 23.50 | 4.17 | 18.61 | 18.61 | 118.69 | 128.81 | 0.8077 | 1.83 | 16.19 | -- | 12.68 | 12.05 | 14.56 | 13.73 | 66.23 | 62.81 | 15.70 | 15.85 | 2.18 | 74.02 | 0.0097 | -- | 8.92 | 12.24 | 57.30 | 12.45 | 16.93 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Chescapmanager LLCas of 31 Mar 2024 | 8.33m | 2.18% |
| Tidal Investments LLCas of 31 Mar 2024 | 6.60m | 1.73% |
| The Vanguard Group, Inc.as of 30 Jun 2024 | 6.56m | 1.72% |
| Global X Investments Canada, Inc.as of 30 Jun 2024 | 3.64m | 0.95% |
| Dimensional Fund Advisors LPas of 04 Jul 2024 | 3.16m | 0.83% |
| Point72 Asset Management LPas of 31 Mar 2024 | 3.12m | 0.82% |
| Two Sigma Investments LPas of 31 Mar 2024 | 1.55m | 0.41% |
| Vanguard Fiduciary Trust Co.as of 31 Mar 2024 | 1.50m | 0.39% |
| Citadel Securities LLCas of 31 Mar 2024 | 1.07m | 0.28% |
| Global X Management Co. LLCas of 31 Mar 2024 | 1.00m | 0.26% |
